glp-1 drugs for parkinson's disease Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine An analysis on the role

doi: 10.2298/ABS1203927K 126

Hernndez-RodasMValenzuelaREcheverraFRincn-CerveraMEspinosaAIllescaPet alSupplementation with docosahexaenoic acid and extra virgin olive oil prevents liver steatosis induced by a high-fat diet in mice through PPAR- and Nrf2 upregulation with concomitant SREBP-1c and NF-kB downregulation

In vitro studies, Jang, G observed a sustained high level of field potentials in the CA1 region by treating hippocampal brain slices with ketamine in vitro, suggesting a long-lasting change in synaptic plasticity [18]

Our content and product recommendations are for informational purposes only and are not intended as medical advice